Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$52.16 - $64.19 $95,870 - $117,981
-1,838 Reduced 14.99%
10,424 $655,000
Q3 2023

Nov 14, 2023

SELL
$57.77 - $65.93 $83,419 - $95,202
-1,444 Reduced 10.54%
12,262 $708,000
Q2 2023

Aug 14, 2023

SELL
$60.95 - $75.51 $662,160 - $820,340
-10,864 Reduced 44.22%
13,706 $853,000
Q1 2023

May 15, 2023

BUY
$70.23 - $86.01 $108,294 - $132,627
1,542 Added 6.7%
24,570 $1.78 Million
Q4 2022

Feb 14, 2023

SELL
$67.18 - $84.11 $37,553 - $47,017
-559 Reduced 2.37%
23,028 $1.85 Million
Q2 2022

Aug 15, 2022

SELL
$66.18 - $83.18 $132,624 - $166,692
-2,004 Reduced 7.83%
23,587 $1.79 Million
Q1 2022

May 16, 2022

SELL
$66.02 - $79.71 $29,709 - $35,869
-450 Reduced 1.73%
25,591 $2.03 Million
Q4 2021

Feb 14, 2022

SELL
$63.34 - $74.11 $6,840 - $8,003
-108 Reduced 0.41%
26,041 $1.91 Million
Q3 2021

Nov 15, 2021

BUY
$68.67 - $84.02 $39,210 - $47,975
571 Added 2.23%
26,149 $1.8 Million
Q2 2021

Aug 16, 2021

BUY
$79.87 - $87.53 $73,081 - $80,089
915 Added 3.71%
25,578 $2.15 Million
Q1 2021

May 14, 2021

SELL
$76.02 - $100.5 $146,262 - $193,362
-1,924 Reduced 7.24%
24,663 $2 Million
Q4 2020

Feb 16, 2021

SELL
$80.74 - $97.7 $302,694 - $366,277
-3,749 Reduced 12.36%
26,587 $2.31 Million
Q3 2020

Nov 16, 2020

SELL
$85.07 - $109.69 $380,773 - $490,972
-4,476 Reduced 12.86%
30,336 $2.72 Million
Q2 2020

Aug 14, 2020

SELL
$74.18 - $108.93 $282,032 - $414,151
-3,802 Reduced 9.85%
34,812 $3.62 Million
Q1 2020

May 15, 2020

BUY
$63.18 - $85.97 $544,232 - $740,545
8,614 Added 28.71%
38,614 $2.83 Million
Q4 2019

Feb 14, 2020

SELL
$73.04 - $95.72 $219,120 - $287,160
-3,000 Reduced 9.09%
30,000 $2.62 Million
Q3 2019

Nov 14, 2019

SELL
$72.82 - $86.52 $509,739 - $605,640
-7,000 Reduced 17.5%
33,000 $2.45 Million
Q2 2019

Aug 14, 2019

SELL
$73.52 - $88.7 $1.99 Million - $2.39 Million
-27,000 Reduced 40.3%
40,000 $3.4 Million
Q1 2019

May 15, 2019

BUY
$63.56 - $88.17 $953,400 - $1.32 Million
15,000 Added 28.85%
67,000 $5.76 Million
Q4 2018

Feb 14, 2019

BUY
$58.5 - $69.94 $702,000 - $839,280
12,000 Added 30.0%
52,000 $3.31 Million
Q3 2018

Nov 14, 2018

BUY
$61.75 - $74.23 $308,750 - $371,150
5,000 Added 14.29%
40,000 $2.76 Million
Q2 2018

Aug 14, 2018

BUY
$60.85 - $83.98 $791,050 - $1.09 Million
13,000 Added 59.09%
35,000 $2.35 Million
Q1 2018

May 15, 2018

SELL
$83.06 - $100.98 $1.08 Million - $1.31 Million
-13,000 Reduced 37.14%
22,000 $1.83 Million
Q3 2017

Nov 14, 2017

BUY
$109.15 - $138.27 $3.82 Million - $4.84 Million
35,000
35,000 $4.09 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Weiss Multi Strategy Advisers LLC Portfolio

Follow Weiss Multi Strategy Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.